SCHEMBL4175343

SCHEMBL4175343

COc1ccc(N2C(=O)[C@H](OCc3ccccc3)[C@@H]2CF)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 3/20 0.46
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
TSHR P16473 1/20 0.44
HSD11B1 P28845 1/20 0.41
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MCOLN3 Q8TDD5 1/20 0.41
PSEN1 P49768 1/20 0.41
PSEN2 P49810 1/20 0.41
APH1B Q8WW43 1/20 0.41
NCSTN Q92542 1/20 0.41
APH1A Q96BI3 1/20 0.41
PSENEN Q9NZ42 1/20 0.41
ALDH1A1 P00352 3/20 0.40
LMNA P02545 2/20 0.40
GFER P55789 1/20 0.40
RGS4 P49798 1/20 0.40
RGS8 P57771 1/20 0.40
CES2 O00748 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4185767 0.89 SOAT1 (0.46) SOAT1MEN1KMT2ATSHRHSD11B1
SCHEMBL4178629 0.86 SOAT1 (0.47) SOAT1MEN1KMT2ATSHRHSD11B1
SCHEMBL13302731 0.84 SOAT1 (0.48) SOAT1MEN1KMT2ATSHRHSD11B1
SCHEMBL3335606 0.81 SOAT1 (0.46) SOAT1MEN1KMT2ATSHRHSD11B1
SCHEMBL13778892 0.81 SOAT1 (0.46) SOAT1MEN1KMT2ATSHRHSD11B1
SCHEMBL4177587 0.81 SOAT1 (0.44) SOAT1MEN1KMT2ATSHRHSD11B1
SCHEMBL4180055 0.81 SOAT1 (0.44) SOAT1MEN1KMT2ATSHRHSD11B1
SCHEMBL4177583 0.81 SOAT1 (0.44) SOAT1MEN1KMT2ATSHRHSD11B1
SCHEMBL4177579 0.81 SOAT1 (0.44) SOAT1MEN1KMT2ATSHRHSD11B1
SCHEMBL4178627 0.79 MEN1 (0.47) SOAT1MEN1KMT2ATSHRHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090186868-A1 Taxane Compound Having Azetidine Ring Structure DAIICHI SANKYO COMPANY LIMITED (JP) 2009-07-23 US disclosed
US-20090186868-A1 Taxane Compound Having Azetidine Ring Structure DAIICHI SANKYO COMPANY LIMITED (JP) 2009-07-23 US disclosed
US-20090186868-A1 Taxane Compound Having Azetidine Ring Structure DAIICHI SANKYO COMPANY LIMITED (JP) 2009-07-23 US disclosed
EP-1942109-A1 TAXANE COMPOUND WITH AZETIDINE RING STRUCTURE Daiichi Sankyo Company, Limited (JP) 2008-07-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186868-A1 Taxane Compound Having Azetidine Ring Structure ABCC1, AZI2, TPD52L2 SOAT1 3842/4885MEN1 1676/4885KMT2A 950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.